CYCL
Cycclone Inc., together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, the company engages in residential and commercial real estate investment. The company was formerly known as China Dasheng Biotechnology Co. and changed its name to Cycclone Inc. in May 2025. Cycclone Inc. was founded in 2004 and is based in Lanzhou, China.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | 0.00 | $0 | $7,860 |
| 2025 Q2 | -0.00 | $0 | -$31,329 |
| 2025 Q1 | 0.00 | $0 | -$14,000 |
| 2025 Q4 | 0.02 | $0 | — |
| 2024 Q2 | -0.00 | $0 | -$58,490 |
| 2024 Q1 | -0.00 | $0 | — |
| 2024 Q3 | -0.00 | $0 | -$28,860 |
| 2023 Q2 | -0.00 | $0 | -$91,570 |